INS and diabetes mellitus: In animal models of hypertension and DM with evidence of nephropathy, AZL-M induced superior antihypertensive, insulin-sensitizing and anti-proteinuric effects as compared to olmesartan medoxomil (Kusumoto et al., 2011).